The practical management of glucose-insulin infusions in the intensive care patient

Intensive Care Medicine
D B McWilliam

Abstract

Intensive Care patients given intravenous infusions of strong glucose often develop hyperglycaemia requiring insulin. A simple method is described for regulating these insulin requirements during infusions of 50% glucose based on beside monitoring of blood glucose.

References

Dec 6, 1975·Lancet·W A Brunton, I W Percy-Robb
Sep 25, 1976·Lancet·J R Stradling
Nov 6, 1976·Lancet·S J IqbalI D Watson
Feb 12, 1977·British Medical Journal
Mar 1, 1979·The Journal of Small Animal Practice·D B Church, A D Watson
Aug 23, 1975·British Medical Journal·E W KraegenY O Chia
May 22, 1976·British Medical Journal·S G Ball, A S Hughes
Jan 1, 1972·Nutrition and Metabolism·P U Heuckenkamp, N Zöllner
Sep 1, 1972·Annals of Surgery·S J DudrickA T Maynard
Aug 10, 1974·British Medical Journal·B ScherstenR Ekman

❮ Previous
Next ❯

Citations

Mar 25, 2006·Nursing in Critical Care·Sharon PrestonAndrew Padkin
Nov 1, 1980·Intensive Care Medicine·A M Woolfson
Dec 16, 1998·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·I J Gordon, E S Jones
Jan 30, 2004·Diabetes Care·Stephen ClementUNKNOWN American Diabetes Association Diabetes in Hospitals Writing Committee
Jan 1, 1996·Advances in Health Sciences Education : Theory and Practice·J J Perkins, R W Sanson-Fisher
Jan 10, 2009·BMC Medical Education·Andrew B SymonsElie A Akl
Jul 22, 2004·Anaesthesia and Intensive Care·S LaverA Padkin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.